Company Monitoring Page for Incyte

latest headlines for company on cafepharma

Incyte (INCY) Q3 Earnings and Revenues Beat Estimates
Yahoo/Zacks.com
Tue, 11/2/21 - 10:49 am
Tags:
Incyte, earnings
Lilly, Incyte: Olumiant Superior to Placebo in Scalp Hair Regrowth as Early as 24 Weeks
Marketwatch
Fri, 10/1/21 - 10:51 am
Tags:
Lilly, Incyte, clinial trials, olumiant, alopecia areata
Incyte and Syndax to jointly develop and commercialize axatilimab
Pharmaceutical Business Review
Tue, 09/28/21 - 12:01 pm
Tags:
Incyte, Syndax Pharma, axatilimab, graft vs host disease
Incyte on a Roll with Two FDA Wins in Two Days
BioSpace
Thu, 09/23/21 - 10:55 pm
Tags:
Incyte, FDA, Jakafi, graft vs host disease, ruxolitinib, atopic dermatitis
Incyte nabs approval of topical ruxolitinib in atopic dermatitis, but gets slapped with JAK warning
Endpoints
Wed, 09/22/21 - 11:17 am
Tags:
FDA, Incyte, atopic dermatitis, ruxolitinib
BioMarin stands tall with first approved drug for rare disease that causes dwarfism
MedCity News
Sat, 08/28/21 - 08:57 pm
Tags:
Biomarin, Europe, achondroplasia, dwarfism, Incyte, MorphoSys
Lilly has a bad hair day as Pfizer rival hits the mark in alopecia
Pharmaforum
Wed, 08/4/21 - 10:50 pm
Tags:
Eli Lilly, Incyte, Pfizer, alopecia areata, ritlecitinib, clinical trials
FDA unsurprisingly brings down the hammer on Incyte's PD-1 — drawing a line for future accelerated approvals
Endpoints
Mon, 07/26/21 - 09:36 am
Tags:
Incyte, retifanlimab, FDA, anal cancer
No fast way to eighth place for Incyte
EP Vantage
Fri, 06/25/21 - 10:58 am
Tags:
Macrogenics, Incyte, retifanlimab, monoclonal antibodies, FDA
FDA slams Incyte's PD-1 over single-arm study, low response and trial deaths
Endpoints
Wed, 06/23/21 - 11:06 am
Tags:
Incyte, FDA, clinical trials, retifanlimab
Incyte hits 2nd FDA delay in span of days, this time for atopic dermatitis hopeful ruxolitinib cream
Fierce Pharma
Sat, 06/12/21 - 10:23 pm
Tags:
Incyte, atopic dermatitis, ruxolitinib, FDA
Incyte the latest to fall victim to JAK scrutiny as FDA pushes back Jakafi review in GVHD
Fierce Pharma
Tue, 06/8/21 - 09:42 pm
Tags:
Incyte, FDA, JAK inhibitors
ASCO 2021: Watch for Sanofi/Sloan Kettering, Incyte, Exelixis and AstraZeneca
BioSpace
Thu, 05/20/21 - 12:35 pm
Tags:
ASCO 2021, Sanofi, Sloane Kettering, Incyte, AstraZeneca, Exelixis, oncology
Incyte’s Ruxolitinib Cream Shows Promise for Vitiligo in Phase III Trials Published: May 17, 2021 By Brandon May
BioSpace
Mon, 05/17/21 - 11:02 pm
Tags:
Incyte, ruxolitinib, vitiligo, clinical trials
Incyte’s PD-(L)1 inhibitor headed for an ODAC showdown next month
Endpoints
Thu, 05/13/21 - 12:06 pm
Tags:
Incyte, FDA, ODAC, anal cancer, retifanlimab
Incyte to pay $12.6 million to resolve drug charity kickback claims
Reuters
Fri, 05/7/21 - 10:54 am
Tags:
Incyte, Jakafi, kickbacks, Medicare
Lilly claims promising finding in failed study of COVID-19 drug
BioPharma Dive
Thu, 04/8/21 - 07:40 pm
Tags:
Eli Lilly, Incyte, COVID-19, baricitinib
Incyte Drug Misses Endpoint in COVID-Respiratory-Distress Trial
TheStreet.com
Sun, 03/21/21 - 11:50 pm
Tags:
Incyte, Jakafi, clinical trials, COVID-19, ARDS
Jakafi failed the primary endpoint in a Covid-19 study. But Incyte is still going to FDA with a compassionate use pitch
Endpoints
Fri, 03/19/21 - 10:49 am
Tags:
Jakafi, Incyte, COVID-19, clinical trials
Eli Lilly, Incyte Report Positive Results For Baricitinib In Alopecia Areata Treatment
NASDAQ
Wed, 03/3/21 - 10:53 am
Tags:
Eli Lilly, Incyte, baricitinib, alopecia areata

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.